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p130Cas is a polyvalent adapter protein essential for car-
diovascular development, and with a key role in cell move-
ment. In order to identify the pathways by which p130Cas
exerts its biological functions in endothelial cells we
mapped the p130Cas interactome and its dynamic
changes in response to VEGF using high-resolution mass
spectrometry and reconstruction of protein interaction
(PPI) networks with the aid of multiple PPI databases. VEGF
enriched the p130Cas interactome in proteins involved in
actin cytoskeletal dynamics and cell movement, including
actin-binding proteins, small GTPases and regulators or
binders of GTPases. Detailed studies showed that p130Cas
association of the GTPase-binding scaffold protein, IQ-
GAP1, plays a key role in VEGF chemotactic signaling, en-
dothelial polarization, VEGF-induced cell migration, and en-
dothelial tube formation. These findings indicate a cardinal
role for assembly of the p130Cas interactome in mediating
the cell migratory response to VEGF in angiogenesis, and
provide a basis for further studies of p130Cas in cell
movement. Molecular & Cellular Proteomics 16: 10.1074/
mcp.M116.064428, 168–180, 2017.
Vascular Endothelial Growth Factor (VEGF1 or VEGF-A) is
essential for angiogenesis during development and in the
pathogenesis of human pathologies including cancer and eye
diseases (1, 2). VEGF stimulates its diverse cellular functions
in endothelial cells through high affinity binding to two tyro-
sine kinase receptors, VEGF receptor 1 (VEGFR1 or Flt-1) and
VEGFR2 (or KDR), though VEGFR2 is largely responsible for
functional VEGF-triggered signal transduction (3, 4). VEGFR2
is activated through ligand-stimulated receptor dimerization
and trans(auto)phosphorylation of multiple tyrosine residues
in the cytoplasmic domain (5, 6), inducing multiple signaling
events followed by early and long-term cellular effects includ-
ing production of the vasoactive mediators, prostacyclin and
nitric oxide, increased cell survival, migration, proliferation
and angiogenesis (4, 6–14). Neuropilin-1 (NRP1) is a corecep-
tor for VEGF in endothelial cells, and is essential for embry-
onic angiogenesis and vascular development (15–17). NRP1
is thought to act as a coreceptor for VEGF by forming com-
plexes with VEGFR2, which enhance intracellular signaling,
cell migration, and angiogenesis (18). In vivo, VEGF binding to
NRP1 appears to be largely dispensable for embryonic vas-
cular development, but is required for perinatal retinal vascu-
larization, and for post-natal angiogenesis in pathophysiolog-
ical settings (19).
We previously identified a key role for the p130Cas adaptor
protein in mediating VEGFR2/NRP1-dependent endothelial
cell migration stimulated by VEGF and PDGF-induced migra-
tion in vascular smooth muscle cells (20, 21). A critical role for
p130Cas, encoded by the Bcar1 gene, in cardiovascular de-
velopment is supported by the phenotype of Bcar1 null mice
(22), which die in utero with severe defects in the heart and
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vasculature seen at embryonic days (E) 11.5–12.5 when
p130Cas is predominantly expressed in the cardiovascular
system of wild type mice. In human endothelial cells, VEGF
rapidly stimulates p130Cas tyrosine phosphorylation in a
NRP1-dependent manner, and VEGF-induced endothelial cell
migration and angiogenesis are inhibited by either p130Cas-
targeted siRNA or by overexpression of a p130Cas mutant
that is nonphosphorylatable at tyrosine residues in the sub-
strate domain (20).
p130Cas is a crucial node in chemotactic signaling in di-
verse cells types, able to interact with multiple binding part-
ners implicated in the regulation of cell migration, including
Crk (C10 regulator of kinase), p60 c-Src, FAK and protein
tyrosine kinase 2 (PYK2) (23, 24). p130Cas binding to intra-
cellular interactors mediates activation of downstream effec-
tors such as the guanine-exchange factors (GEFs) DOCK180-
ELMO (Engulfment and cell motility) and C3G, which in turn
enhance the activity of the small GTPases Rac and Rap
(25–28), essential for actin reorganization in lamellipodia and
membrane ruffle formation. Hitherto, p130Cas protein-protein
interactions have been identified on a case by case basis from
candidate-based studies using coimmunoprecipitation exper-
iments (23, 24). The structural features of p130Cas that fit it to
the role of a polyvalent hub for protein-protein interactions,
and its essential functions in cell motility, in cardiovascular
development and in endothelial VEGF signaling, revealed by
mouse genetic and cellular studies, make p130Cas a partic-
ularly attractive candidate for interactome analysis using an
unbiased proteomic and systems biology approach. We
therefore sought to define the p130Cas-interacting partners in
endothelial cells relevant for VEGF-driven chemotaxis using
mass spectrometry combined with bioinformatic analysis of
p130Cas-associated proteins. Our findings reveal that VEGF
stimulation enriched the p130Cas interactome in several ma-
jor classes of protein involved in cell movement or cellular
processes linked to cell motility, including many novel
p130Cas-interacting proteins. Targeted studies on selected
components of the p130Cas interactome supported the initial
proteomics analysis and identified novel mediators of endo-
thelial cell motility and angiogenesis. This is the first pro-
teomic analysis of the p130Cas interactome, and its results
demonstrate a key role for p130Cas and its interactome in
VEGF angiogenic signaling in endothelial cells.
MATERIALS AND METHODS
Immunoprecipitation—HUVECs cultured on 10 cm dishes, which
had been infected with adenoviruses (Ad) encoding either wild-type
(WT) p130Cas (Ad.p130Cas), or a p130Cas mutant with 15 tyrosine
residues mutated to phenylalanine (Ad.p130Cas15F), were treated
with VEGF (0,10, 30 and 60 min) in three independent experiments,
and then lysed with 10 mM Tris-HCl pH 7.4, 50 mM NaCl, 5 mM EDTA,
1% Triton-X100, CompleteTM protease inhibitor mixture EDTA free
and phosphatase inhibitors (Sigma, Dorset, UK). Lysates were cen-
trifuged at 20,000  g for 10 min to remove insoluble debris, pre-
cleared by mixing with A/G agarose beads in lysis buffer for 1 h with
constant mixing, and were then used for immunoprecipitation (lysate
from one 10 cm dish of cells per immunoprecipitation) with p130Cas
antibody (1:50 dilution) for 16 h. In addition, HUVECs which had been
infected with Ad.p130Cas (WT), were treated with VEGF (0,10, 30,
and 60 min) in three independent experiments, lysed as above, and
used for immunoprecipitation with isotype-matched control antibody
(mouse IgG; 1:10 dilution; Santa Cruz Biotechnology, Dallas, TX,
catalog number sc-2025) for 16 h. All immunocomplexes were cap-
tured with Protein A/G PLUS agarose beads (Santa Cruz) for 1 h.
Immunoprecipitates were washed three times with lysis buffer, and
separated on SDS-PAGE gels. Immunoprecipitates that were used for
mass spectrometry were washed three times with lysis buffer and
twice with PBS to remove detergent. All above procedures were
carried out on ice or at 4 °C. Beads were stored on dry ice, and
immunoprecipitated proteins were eluted in a 2-step process (29).
First, beads were incubated with 60 l eluting buffer 1 (2 M urea, 50
mM Tris-HCl pH7.5, and 5 g/ml trypsin (modified sequencing grade
trypsin); Promega, Southampton, UK) at 27°C for 30 min under gentle
agitation. Then, samples were centrifuged and the supernatants were
placed in a fresh tube. For the second elution step 2  25 l elution
buffer 2 (2 M urea, 50 mM Tris-HCl pH7.5, and 1 mM DTT) was added
to the beads. All supernatants were combined and allowed to digest
overnight at room temperature. The following morning, samples were
alkylated with 20 l iodoacetamide (5 mg/ml) for 30 min in the dark.
This reaction was stopped with 1 l of 100% trifluoroacetic acid
(TFA), and the sample (110 l) was immediately loaded onto equil-
ibrated C18 StageTips, prepared as described previously (30). Sam-
ples were added to the activated tips, desalted using 2  50 l of 1%
TFA solution, and eluted with 2  25 l of 50% ACN and 0.1% TFA
solution. Final eluates were combined and concentrated using a
CentriVap concentrator (Labconco, Fort Scott, KS), resuspended in
12 l 0.1% TFA and analyzed by mass spectrometry.
Mass Spectrometry and Data Analysis—The samples prepared
from immunopreciptates which had been obtained from three inde-
pendent cultures of HUVECs, each treated with VEGF for different
times, were analyzed on a Q-Exactive mass spectrometer (Thermo
Fisher Scientific, Loughborough, UK) connected to a Dionex Ultimate
3000 (RSLCnano) chromatography system (Thermo Fisher Scientific)
incorporating an autosampler. A total of 5 l of tryptic peptides from
each sample was loaded onto a homemade column (100 mm length,
75 m inside diameter), packed with 1.9 m ReprosilAQ C18 (Dr.
Maisch GMBH, Ammerbuch-Entringen, Germany) and separated by
an increasing acetonitrile gradient using a 40 min reverse-phase
gradient (from 3–32% Acetonitrile) at a flow rate of 250 nL/min. The
mass spectrometer was operated in positive ion mode with a capillary
temperature of 220°C and a potential of 2000 V applied to the cap-
illary. All data were acquired with the mass spectrometer operating in
automatic data-dependent switching mode. A high-resolution MS
scan (350–2000 Da) was performed using the Orbitrap to select the
12 most intense ions for fragmentation and MS/MS analysis. The
MaxQuant software suite (v 1.5.0.25) containing the in-built Androm-
eda search engine was used to identify the proteins from a human
database (Uniprot HUMAN, release 2012_01) containing 20,242 en-
tries, and determine their relative concentration by label-free quanti-
fication. For database searches, the precursor mass tolerance was
set to 20 ppm for first searches and 4.5 ppm for main Andromeda
search. MaxQuant default parameters were used with the exception
of minimum ratio count and LFQ minimum ratio count set to 1. The
search included a fixed modification of Carbamidomethyl (C) and
variable modifications of Oxidation (M);Acetyl (Protein N-term). A fully
tryptic specific search was used. The maximum number of missed
cleavages was set at 2 and minimum peptide length was set to 7
amino acids. An FDR of 0.01 was set for peptide and protein identi-
fications. Match between runs was selected with a matching time
window of 0.7 min and alignment time window of 20 min. The pres-
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ence of reverse and contaminant identifications was removed from
the dataset. For quantification purposes LFQ intensity values from
MaxQuant were used for statistical analysis. All samples were ana-
lyzed in technical duplicates (labeled “a” and “b” in supplemental
tables and biological triplicates, and as such every MS file was
considered separately for the subsequent statistical analysis. Full
details of peptide sequences, and protein identifications (including
accession numbers) can be found in supplemental Tables S1 and S2.
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE (31) partner reposi-
tory with the dataset identifier PXD003902 (http://www.ebi.ac.uk/
pride/archive/).
Determining VEGF Induced Interactomes of Wild-type and Mutant
p130cas—Log-transformed protein intensities of p130Cas immuno-
precipitates from HUVECs transduced with Ad expressing either
p130Cas (Ad.p130Cas), or p130Cas15F (Ad.p130Cas15F, mutant)
and which had been VEGF treated (0, 10, 30 and 60 min) were
compared with the corresponding isogenic controls samples from
HUVECs transduced with Ad.p130Cas (WT), and which had been
VEGF treated (0, 10, 30 and 60 min). The comparison was performed
using BDiffProt algorithm (32), which identified differentially ex-
pressed proteins between the control (isogenic control, transduced
with Ad.p130Cas) and noncontrol (p130cas immunoprecipitates,
transduced with Ad.p130Cas or Ad.p130Cas15F) samples. We chose
BDiffProt because it was shown to have superior performance over
other methods that are commonly used to find differentially ex-
pressed proteins. Additionally, it does not require missing data points
to be inputed and performs well on both normal and nonnormal
protein intensity data (32). However, because BDiffProt has not pre-
viously been used to analyze data from affinity purification combined
with Mass-Spectrometry (AP-MS) we confirmed the suitability of this
algorithm by using it to analyze a previously published AP-MS derived
data set (33). Two sets of samples, containing empty vectors (nega-
tive controls) and PHD3 baits were analyzed. BDiffProt, combined
with a fold change threshold of 2, identified 1473 proteins to have
differential intensities between these two types of samples. In the
original publication (33), 1279 proteins were detected to be differen-
tially expressed using t test and the same fold-change threshold.
Approximately 91% of the proteins identified in the original publica-
tion were also identified by the BDiffProt analysis (supplemental Fig.
S1). The details of the BDiffProt output and Bayesian analysis (includ-
ing the proteins excluded from further analysis) are given in supple-
mental Tables S3 and S4 respectively. Proteins which were identified
to be differentially expressed by BDiffProt algorithm and had at least
2-fold increase between wild-type/mutant p130cas transduced sam-
ples and the isogenic controls at each time of VEGF treatment were
considered to be potential p130cas interactors. Proteins that were not
selected in the above process were discarded from further analysis.
For the potential p130cas interactors, the intensities in samples
treated with VEGF for 10, 30 and 60 min were further compared with
the intensities in untreated samples (0 min VEGF treatment) using
BDiffProt algorithm. Proteins that were found to be differentially ex-
pressed and had at-least 2-fold increase in intensities between un-
treated and VEGF treated samples were considered to form the VEGF
induced interactome of wild-type and mutant p130cas. Fold-changes
were calculated by first replacing the missing intensities with the
minimum intensity in the dataset (34, 35), calculating the average
intensities in each of 10, 30, and 60 min VEGF treated and untreated
group of samples, and then dividing the average intensity of each
treated group by that of the untreated group.
Gene Ontology(GO) Enrichment Analysis—The gene ontology en-
richment of each cluster of interactors were analyzed using the Gene
Ontology Consortium’s enrichment analysis tool (http://geneontology.
org/page/go-enrichment-analysis).
Cell Polarity Assay—HUVECs were plated onto coverslips to form
a confluent monolayer. The center of the coverslip was scoured with
a pipette tip, removing cells and leaving a gap. Cells were incubated
for 90 min to allow them to polarize toward the scratch, then fixed in
4% PFA. Cells were stained with an anti-GM130 (Golgi marker) anti-
body. Actin and nuclei were visualized using TRITC-phalloidin and
DAPI, respectively.
Other Methods—Cell culture, adenoviral construction and infec-
tion, recombinant protein generation and pulldowns, immunofluores-
cent staining and confocal imaging, focal adhesion isolation, and
assays of chemotaxis and angiogenesis in cocultures, were per-
formed as previously described (18, 20, 36) and are detailed in sup-
plementary materials.
Experimental Design and Statistical Rationale—For quantification
purposes LFQ intensity values from MaxQuant were used for statis-
tical analysis. All samples were analyzed in technical duplicates (la-
beled “a” and “b” in supplemental tables and biological triplicates
(labeled 1–3 in supplemental Tables S1 and S2), and as such every
MS file was considered separately for the subsequent statistical
analysis.
The data displayed in the graphs are means, with error bars rep-
resenting the standard error of the mean (s.e.m.), n values for each
experiment are detailed in the appropriate figure legends. Statistical
analysis was performed by two-way analysis of variance with a Bon-
ferroni post-test. A p value of 0.05 was considered significant.
RESULTS
Identification of the Endothelial Cell p130Cas Interactome
and Dynamic Regulation by VEGF—To identify the VEGF-
responsive p130Cas interactome in endothelial cells mass
spectrometry (MS) analysis was performed on p130Cas im-
munoprecipitates (IPs) prepared from cells treated with VEGF
for 10, 30, and 60 min in three independent experiments (Fig.
1A). In order to enrich the signal for p130Cas-interacting
proteins to a detectable level for label-free MS, we over-
expressed wild-type (WT) p130Cas in endothelial cells, and to
determine which interactions were specific for tyrosine phos-
phorylated p130Cas, we additionally compared immunopre-
cipitates prepared from cells over-expressing p130CasWT
with those expressing a nonphosphorylatable p130Cas
mutant (p130Cas15F), in which all 15 potential tyrosine
phosphorylation sites in the substrate domain were mutated
to phenylalanine (20). We also compared immunoprecipi-
tates prepared from cells overexpressing p130CasWT or
p130Cas15F with immunoprecipitates prepared from cells
overexpressing p130CasWT using an isotype-matched
control antibody. VEGF stimulated a striking increase in
p130Cas tyrosine phosphorylation in HUVECs expressing
Ad.p130CasWT, which was suppressed in HUVECs express-
ing Ad.p130Cas15F (Fig. 1B). Similar amounts of total
p130Cas were immunoprecipitated from cells expressing
p130CasWT and p130Cas15F (Fig. 1A) as confirmed by mass
spectrometry (supplemental Fig. S2).
MS analysis identified proteins in the p130Cas interactome
that were enriched in IPs prepared from cells in all three
independent experiments, both expressing p130CasWT as
compared with cells expressing p130Cas15F, and in IPs pre-
pared from cells expressing p130CasWT that had been
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treated with VEGF for 10, 30 or 60 min as compared with
untreated cells (Fig. 1C). VEGF induced significant changes in
the intensities of 163 and 45 proteins, respectively, in WT and
mutant p130cas-expressing cells (Figs. 1D and 2, supplemen-
tal Tables S5 and S6). These proteins constitute the VEGF
induced interactomes of p130CasWT and p130cas15F, re-
spectively. The largest number of VEGF induced p130casWT
interactors were identified after 60 min VEGF treatment, and
the second largest group were persistent interactors, that is
their intensities increased after 10 min VEGF treatment and
did not change significantly between 10, 30, and 60 min
treatment (Fig. 2). Components of the p130casWT interac-
tome showed different temporal patterns of interaction: per-
sistent interactors, delayed interactors of p130casWT, which
had higher intensities at 30 and 60 min after VEGF stimulation
than at 10 min; late interactors, with higher intensities at 60
min after VEGF treatment than at 10 or 30 min; returning
interactors which had higher intensities at 10 and 60 min
following VEGF treatment than at 30 min, and early interactors
of p130casWT, i.e. have higher intensities at 10 min following
VEGF treatments than 30 or 60 min.
The p130cas15F interactome was much smaller, the largest
group in this interactome comprising transient interactors,
exhibiting higher intensities at 10 and 30 min of VEGF treat-
ment than at 60 min with few proteins early or persistent
interactors (Fig. 2). Few proteins were found in both the
p130casWT and p130cas15F interactomes at any of the times
of VEGF treatment, indicating little overlap in the WT and
mutant p130Cas interactomes.
Gene Ontology Analysis of the p130Cas Interactome—
These findings indicated that VEGF causes a marked, time-
dependent increase in complexation of p130Cas with a
large number of cellular proteins, and that formation of the
VEGF-dependent p130Cas interactome is strongly depend-
ent on tyrosine phosphorylation of the p130Cas substrate
domain. In order to visualize specific interactome changes
under different conditions, we reconstructed a generic
p130Cas interaction network from the Gene Ontology Con-
sortium database and our MS results, and functionally in-
terpreted the p130Cas interactomes by quantifying the number
of proteins associated with specific gene ontology (GO) anno-
tations that significantly changed depending on the conditions.
FIG. 1. Biochemical and computational workflow for determining the interactomes of mutated and wild type p130cas, before and
after VEGF stimulation. HUVECs were infected with Ad.p130CasWT or Ad.p130Cas15F for 48h. Cells were then incubated for 18 h in EBM
with 0.5% FBS followed by stimulation with or without VEGF for the times indicated. Cells were then lysed and p130Cas was immunopre-
cipitated. A, Representative blot demonstrating immunoprecipitation of a band corresponding to the p130Cas detected in whole cell lysates
(WCL), but not with the IgG control. B, Representative blot of WCLs showing that VEGF treatment increases the amount of tyrosine
phosphorylated (Tyr410) p130Cas in Ad.p130CasWT infected cells but not in cells overexpressing p130Cas15F. C, Overview of the
experimental procedure and downstream analysis. Briefly, confluent HUVECs were infected with either Ad.p130CasWT or Ad.p130Cas15F
for 48h, incubated overnight in EBM/0.5% FBS followed by stimulation with VEGF for 0, 10, 30, or 60 min. Cells were lysed and p130Cas
immunoprecipitated in three independent experiments. Immunoprecipitated proteins were prepared and identified by LC-MS/MS prior to
reconstruction of the p130Cas interactome. See Materials and Methods & supplemental material for further details. D, Number of proteins
showing increased association with p130Cas after VEGF stimulation for the times indicated of cells overexpressing Ad.p130CasWT (black
bars) or Ad.p130Cas15F (open bars). Numbers shown indicate proteins identified in all 3 experiments at each treatment time.
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Clustering analysis revealed dynamic changes in the VEGF
induced p130casWT and interactome following VEGF treat-
ment (Fig. 3). GO enrichment analysis revealed that the
functional groups exhibiting the highest intensities in the
p130casWT interactome at 10, 30 and 60 min following VEGF
treatment included proteins involved in actin filament-based
processes and actin cytoskeletal organization. Other GO
groups featuring in the p130CasWT interactome were those
associated with cellular component organization and biogen-
esis, protein translation, intracellular vesicular protein trans-
port, and regulation of mRNA processing and expression (Fig.
3). Among proteins displaying a persistent and/or delayed
interaction with p130casWT, were cytoskeletal proteins, ac-
tin-binding proteins and regulators of actin filament assembly,
proteins with established roles in cell migration, and several
proteins implicated in angiogenesis (supplemental Table S5).
These included several proteins with known roles in the reg-
ulation of cell migration, and/or endothelial cell function,
VEGF signaling, or angiogenesis, including IQGAP1, Profi-
lin-1, CDC42 binding protein kinase beta (CDC42BPB or myo-
tonic dystrophy-related CDC42-binding kinase (MRCK)),
formin homology domain proteins (FMNL or FHOD 1 and 3),
and RhoGEF and PH domain containing 5 (FGD5). In addition,
VEGF also increased p130casWT interaction with other pro-
teins with established roles in actin filament organization or in
cell migration in other cell types, including aldolase-A, micro-
tubule associated monooxygenase, calponin and LIM domain
containing 2 (MICAL2), spire type actin nucleation factor
1 (SPIRE1), Slit-Robo Rho GTPase activating protein 1
(SRGAP1), cysteine and glycine rich proteins 1 and 2
(CSRP1 and 2), tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein epsilon (YWHAE or
14–3-3 epsilon). VEGF also enriched the p130casWT inter-
actome in a significant number of proteins with roles in
regulation of post-transcriptional mRNA processing, or in
vesicular protein trafficking. In contrast, the mutant
p130cas15F interactome contained far fewer enriched GO
terms than the p130casWT, and no GO enrichment was
detected at 60 min VEGF treatment (Fig. 3). Together, these
results support a central role for p130Cas and its interac-
tome in VEGF regulation of actin cytoskeletal organization
and motility, and identifies novel p130Cas-interacting pro-
teins with potential roles in VEGF and p130Cas mediated
cellular functions.
FIG. 2. Comparison of the dynamic interactomes of wildtype and mutant p130cas during VEGF stimulation. Pie charts showing the
percentage of p130Cas-interacting proteins at each VEGF treatment time point and between times for the WT and mutant p130Cas
overexpressing HUVECs. The diameter of WT and mutant pies is proportional to the interactome size.
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Functional Role of p130Cas Interactome Constituents in
Endothelial Cells—In order to infer with greater confidence
a functional role for individual protein associations with
p130Cas in VEGF signaling relevant for cell movement, we
next examined associations, and their regulation by VEGF
treatment, of selected interactome constituents with endog-
enous p130Cas expressed at a physiological level. We con-
firmed endogenous p130Cas association with three interac-
tors with known roles in cell migration identified in our
interactome analysis, IQGAP1, Profilin-1, and MRCK by
p130Cas immunoprecipitation followed by Western blot with
antibodies specific to these interactors (supplemental Fig. S3,
Fig. 4).
The scaffold protein, IQGAP1, was strongly increased in
the WTp130Cas interactome by VEGF treatment (Fig. 4A).
IQGAP1 is implicated in the regulation of cell motility through
interactions with cell adhesion molecules, such as E-cadherin,
and with the small GTPases, Rac1 and Cdc42, which are
involved in lamellipodia protrusion (36, 37), and is reported to
mediate VEGF-dependent generation of reactive oxygen spe-
cies and endothelial migration via Akt signaling, and angio-
genesis (38–40). However, the interaction between p130Cas
and IQGAP1 has not previously been identified, and it is
unclear how the scaffold function of IQGAP1 mediates its
functional roles in endothelial cells. Western blot of immuno-
precipitates of endogenous p130Cas from endothelial cells
with antibody specific to IQGAP1, confirmed the VEGF-regu-
lated association with p130Cas originally found in p130Cas-
overexpressing cells (Fig. 4B). We therefore examined the
interaction of IQGAP1 and p130Cas in VEGF signaling and
FIG. 3. Comparison of enriched GO terms in the VEGF induced WT and mutant p130Cas interactomes. Enriched GO terms for the WT
(left hand panel) and mutant (right hand panel) p130Cas interactomes were determined using the Gene Ontology Consortium’s enrichment
analysis tool. There were no enriched GO terms in the mutant p130cas interactors at 60 min, therefore, only those enriched GO terms in mutant
p130cas at 10 and 30 min are shown. The color scale indicates fewer proteins associated with GO term (blue) and increasing proteins
associated with GO term denoted by red shading.
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endothelial migratory cell functions in greater detail as an
exemplar of the functional importance of the p130Cas
interactome.
Immunoprecipitation of endogenous p130Cas followed by
IQGAP1Western blot showed that although some constitutive
coimmunoprecipitation of these proteins occurred, VEGF sig-
nificantly increased association of p130Cas with IQGAP1 (Fig.
4B, 4C). VEGF stimulated the association between endoge-
nous IQGAP1 and p130Cas proteins in a time-dependent
manner with a detectable increase at 10 min, and significant
enhancement at 30 min (Fig. 4C). In HUVECs overexpressing
p130CasWT, VEGF increased the p130Cas association with
IQGAP1, but this stimulation was completely blocked by over-
expression of the nontyrosine phosphorylatable p130Cas15F
mutant (Fig. 4D), indicating that interaction between these
proteins was dependent on p130Cas tyrosine phosphoryla-
tion, consistent with our proteomics analysis. The importance
of p130Cas tyrosine phosphorylation for the relay of VEGF
signaling to IQGAP1 was further tested by examining the
effect of p130Cas depletion on VEGF-stimulated IQGAP1 as-
sociation with tyrosine phosphorylation (41). IQGAP1 immu-
noprecipitation with anti-phosphotyrosine antibody in un-
stimulated endothelial cells was low, but was markedly
increased by VEGF treatment for 15 min, an effect that was
abolished by p130Cas knockdown (supplemental Fig. S4A).
Furthermore, inhibition of Src, which is an important mediator
of p130Cas tyrosine phosphorylation, using the selective
inhibitor PP2, strongly reduced VEGF-stimulated IQGAP1 an-
ti-phosphotyrosine immunopreciptation (supplemental Fig.
S4B). In contrast, inhibition of Focal adhesion kinase (FAK)
and the related kinase PYK2, using PF-573,228, had no effect
on VEGF-induced IQGAP1 association with tyrosine phos-
phorylation (supplemental Fig. S4B).
The interaction between p130Cas and IQGAP1 was further
investigated by examining interactions between recombinant
full-length IQGAP1 protein fused to GST (supplemental Fig.
FIG. 4. IQGAP1 associates with p130Cas in a VEGF-dependent manner and also requires p130Cas tyrosine phosphorylation. A, Fold
change in IQGAP1 association with VEGF treatment in HUVECS infected with Ad.p130CasWT as determined by the LFQ intensities. B, C, Cells
were incubated in EBM/0.5% serum for 18 h prior to treatment with VEGF for the times indicated. Cells were lysed and immunoprecipitated
with anti-p130Cas antibody and immunoblotted with antibodies to p130Cas and IQGAP1. Coimmunopreciptated IQGAP1 in C from 3
independent experiments was quantified by densitometry and normalized to total immunopreciptated p130Cas using ImageJ; *p 0.05 versus
0 min time point, n  3. D, HUVECs were infected with either Ad.p130CasWT or Ad.p130Cas15F for 48 h. Adenovirus infected cells, in parallel
with uninfected cells, incubated in EBM/0.5% serum for 18 h followed by stimulation with or without 25 ng/ml VEGF for 30 min. Cells were lysed
and immunoprecipitated with anti-p130Cas antibody and immunoblotted with antibodies to p130Cas and IQGAP1. Blots shown are repre-
sentative of at least 2 independent experiments. E, Cells were transfected with 200 nM siNRP1 or 200 nM siScr for 48h, incubated in EBM/0.5%
serum for a further 18 h, then stimulated with or without VEGF for 30 min, lysed and immunoprecipitated with anti-p130Cas antibody and
immunoblotted with antibodies to p130Cas and IQGAP1. Quantification of coimmunoprecipitated IQGAP1 is shown below. #p  0.05 versus
siScr minus VEGF, *p  0.01 versus siScr plus VEGF, n  3.
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S5A), and endogenous p130Cas. Incubation of GST-IQGAP1
with HUVEC lysates resulted in p130Cas pull-down, and this
interaction was not affected by VEGF treatment of the cells,
indicating that endogenously expressed p130Cas associates
with IQGAP1 (supplemental Fig. S5B). The interaction of
p130Cas with IQGAP1 was further investigated in pull-down
experiments with recombinant p130Cas GST-fusion proteins
containing either the carboxy-terminal or amino-terminal por-
tions of p130Cas. Immunoblot of IQGAP1 in endothelial ly-
sates following incubation with p130Cas GST-fusion proteins
showed that IQGAP1 was selectively pulled down only by the
p130Cas amino-terminal region comprising the tyrosine
phosphorylated kinase substrate domain, the SH3 domain
and the proline-rich region (supplemental Fig. S5C).
NRP1 is important for mediating VEGF signaling via in-
creased p130Cas tyrosine phosphorylation and is strongly
implicated in VEGF regulation of directed endothelial cell
movement (18–20). The role of NRP1 in relaying VEGF-in-
duced signals to larger multimolecular complexes involved in
actin re-organization and cell movement is presently unclear.
Depletion of NRP1 using two specific NRP1-targeted siRNAs
inhibited the VEGF-induced p130Cas association with
IQGAP1 (Fig. 4E and supplemental Fig. S6), indicating that
VEGF stimulates the interaction between IQGAP1 and
p130Cas via an NRP1-dependent pathway.
Role of the p130Cas/IQGAP1 Association in VEGF-induced
Focal Adhesion Assembly, Migration, and Angiogenesis—
VEGF stimulates a redistribution of p130Cas in endothelial
cells to focal adhesions (FA) and the membrane where it
colocalizes with F-actin (supplemental Fig. S7A) (20). VEGF
also caused a marked change in the cellular distribution of
IQGAP1 from a preponderantly diffuse granular cytoplasmic
staining to a pattern of discrete staining at the plasma mem-
brane and increased costaining of IQGAP1 with vinculin in
FAs and with F-actin, particularly in membrane ruffles (sup-
plemental Fig. S7A, S7B).
Because assembly of multimolecular complexes at FAs
plays a key role in regulating cell adhesion to extracellular
matrix and cell movement, we examined the VEGF-dependent
recruitment of IQGAP1 to FAs in isolated FAs prepared from
fibronectin adherent cells using hydrodynamic force (36).
Western blotting and immunostaining showed that isolated
FAs were enriched in the major FA-associated protein, paxil-
lin, whereas Akt was only weakly detected in FAs and was
enriched in the cell body fraction (Fig. 5A, supplemental Fig.
S8). FAs in control cells contained some p130Cas, but VEGF
markedly and rapidly increased p130Cas FA localization, as
judged by Western blot of FA lysates (Fig. 5B). Increased
p130Cas expression in FAs was accompanied by increased
phosphorylation of p130Cas at Y410. Concomitant with ex-
pression of total and phosphorylated p130Cas in FAs, VEGF
also markedly increased colocalization of p130Cas and vin-
culin in isolated FAs as determined by immunofluorescent
staining (Fig. 5C). VEGF promoted IQGAP1 recruitment to FAs
with a similar time-course. IQGAP1 exhibited some localiza-
tion to FAs in control cells, but VEGF caused a striking redis-
tribution of IQGAP1 to membrane ruffles at the cell periphery,
that also colocalized with FAs (Fig. 5D).
A key step in the directed migration and angiogenic sprout-
ing of endothelial cells is their polarization, characterized by
the formation of a leading edge and elaboration of filopodia
orientated toward a gradient of chemoattractant angiogenic
cytokine. Endothelial cell polarization was examined initially in
a scratch wound assay in which endothelial cells migrate into
the wound area of a cell monolayer. Following wounding,
endothelial cells become polarized, indicated by the orienta-
tion of the juxtanuclear Golgi apparatus toward the wounded
area. IQGAP1 knockdown strongly inhibited endothelial po-
larization in this assay (Fig. 6A).
We next tested the effect of IQGAP1 knockdown on the
directed migration of endothelial cells in response to a VEGF
gradient. IQGAP1 knockdown significantly inhibited VEGF-
induced chemotaxis of endothelial cells, similar to the ef-
fects of p130Cas knockdown (Fig. 6B). We also examined
the role of IQGAP1 and p130Cas in the angiogenic response
to VEGF in an organotypic coculture angiogenesis assay.
Targeted siRNAs to IQGAP1 and p130Cas significantly
reduced the vascular network area generated in response
to VEGF treatment for 7 days (Fig. 6C and supplemental
Fig. S9).
Role of the p130Cas/IQGAP1 Association in VEGF Signal-
ing—We next investigated how p130Cas mediates signal re-
lay from VEGF to IQGAP1 and more distal signaling networks
important for cell migration. Knocking down IQGAP1 by
siRNA had no effect on VEGF stimulation of p130Cas tyrosine
phosphorylation or phosphorylation of VEGFR2 (supplemen-
tal Fig. S10) indicating that tyrosine kinase pathways mediat-
ing p130Cas tyrosine phosphorylation are upstream and in-
dependent of the VEGF-dependent association between
p130Cas and IQGAP1.
The role of IQGAP1 in VEGF signaling was further exam-
ined by studying the effects of IQGAP1 knockdown on key
VEGF signaling cascades important for endothelial cell
migration. IQGAP1-targeted siRNA caused a significant in-
hibition of VEGF-induced Akt activation and eNOS phos-
phorylation at Ser1177, the major Akt-dependent eNOS
phosphorylation site (Fig. 7A, 7B) (42). These findings sug-
gested that the p130Cas interaction with IQGAP1 was im-
portant for Akt activation and downstream eNOS phospho-
rylation. This possibility was investigated by examining the
effect of p130Cas-targeted siRNA on the Akt/eNOS path-
way. Similar to the effects of IQGAP1 knockdown in cells
cultured in parallel, p130Cas depletion strongly inhibited
VEGF-induced Akt activation and eNOS phosphorylation at
Ser1177 (Fig. 7A, 7B, supplemental Fig. S11). Another mech-
anism that could mediate the role of the IQGAP1 interaction
in endothelial cell migration and angiogenesis is recruitment
of the small GTPase Rac1, which has previously been im-
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plicated in the endothelial migratory response to VEGF.
VEGF markedly increased the association between Rac1
and
IQGAP1 as demonstrated by coimmunoprecipitation (Fig. 7C),
consistent with previous findings (37). Preincubation of cells
with a Rac1 inhibitor also significantly reduced VEGF-medi-
ated AKT phosphorylation (Fig. 7D), supporting the conclu-
sion that Rac1 mediates AKT activation downstream of
IQGAP1. However, we could not demonstrate that p130Cas
knockdown using two independent siRNAs significantly re-
duced VEGF-induced stimulation of IQGAP1 association with
Rac1, suggesting that IQGAP1 may additionally modulate
Rac1 activity and Rac1-mediated Akt activation via a
p130Cas-independent pathway.
DISCUSSION
Through its different domains, p130Cas is thought to func-
tion in the assembly of multiprotein signaling complexes re-
quired for remodeling of the actin cytoskeleton during cell
motility (23). The in vivo functions of p130Cas are still poorly
characterized, but the phenotype of p130Cas knockout mice
demonstrates that this molecule is essential for mammalian
embryonic cardiovascular development, p130Cas null mice
display aberrant development of the heart, with thin myocar-
dium, and severe dilatation of blood vessels, whereas other
organs were largely unaffected (22). We have demonstrated
that VEGF induces signaling via a NRP1-dependent p130Cas
pathway that mediates endothelial cell chemotaxis (20). How-
ever, the mechanisms through which p130Cas regulates cell
migration in endothelial cells are largely unknown.
A major conclusion from our analysis is that VEGF stimu-
lates a major enrichment in the p130Cas interactome in pro-
teins involved in actin-binding, the regulation of cell motility,
and/or actin cytoskeletal dynamics. These included proteins
previously found to play roles in cell migration, and/or angio-
genesis and VEGF signaling, including IQGAP1, Profilin-1,
MRCK, aldolase-A and formin homology domain proteins
(FHOD or FMNL) 3. Thus VEGF-induced Profilin-1 phosphor-
ylation is essential for post-natal angiogenesis in response to
wounding and ischemia (43). The CDC42-binding kinase,
MRCK, regulates actin organization in endothelial cell con-
tacts and cell migration in cancer cells (44, 45), aldolase-A
regulates lamellipodia formation (46), and FHOD3 is important
for maintenance of F-actin polymerization at EC junctions and
FIG. 5. VEGF induces localization of p130Cas and IQGAP1 into focal adhesions. Focal adhesion (FA) isolates were prepared as detailed
in Materials and Methods and validated by Western blot and immunofluorescent analysis. A, Representative blots of lysates from either the cell
body (CB) or FA fractions immunoblotted with the indicated antibodies. Paxillin is expressed at higher levels in focal adhesions whereas Akt
and Erk expression is largely limited to the cell body fraction. -actin was used to confirm equal loading. B, Representative blots of isolated
FAs after VEGF treatment. HUVECs were plated onto fibronectin and made quiescent by overnight incubation in EBM/0.5% FBS. Cells were
stimulated for 0 to 60 mins with 25 ng/ml VEGF before FA isolation. C, D, FAs were prepared from HUVECs adhering to fibronectin-coated
coverslips, and stained with antibodies to vinculin (red) and either p130Cas or IQGAP1 (C, D respectively; green). Images shown are
representative of at least 3 different experiments.
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is required for vessel lumenization in angiogenesis (47). The
presence of GTPase-regulating proteins in the p130Cas pro-
teome indicates that p130Cas is an important node for relay
of signals by VEGFRs to small GTPases important for endo-
thelial migration and cellular morphogenesis. For example,
VEGF also increased association of p130Cas with FDG5, an
endothelial-specific protein which plays a key role in vessel
pruning in mice in part through regulation of Cdc42 (48). VEGF
also stimulated p130Cas association with other interactors of
small GTPases, including MRCK, Slit-Robo Rho GTPase
activating protein 1 (SRGAP1) and IQGAP1. Several proteins
previously found to be associated with p130Cas were not
identified by MS in the p130Cas interactome, most notably
FAK and Crk. This may be because of the relatively low
abundance of these interactions in endothelial cells, setting
them below the threshold for detection by MS.
The VEGF-stimulated p130Cas interactome also contained
several mRNA-binding proteins. Previous studies have drawn
attention to FAs as sites of active, rapid mRNA and protein
synthesis during integrin-dependent adhesion cells (49), an
observation which likely reflects a role of actin-based struc-
tures and focal adhesions as scaffolds for polyribosome as-
sembly in cells. Taken together, VEGF-induced enrichment in
the p130Cas interactome of proteins involved in regulation of
cell movement and adhesion, mRNA binding and stability,
suggests an important role of p130Cas in integrating cell
movement with the regulation of protein expression, which
may be important for coordination of these two processes in
the assembly and disassembly of actin filaments and FAs.
IQGAP1 was strongly associated with the VEGF-dependent
p130Cas interactome, a finding that was confirmed independ-
ently by coimmunoprecipitation, by pull-down of p130Cas in
endothelial cell lysates with recombinant IQGAP1, and by
pull-down of IQGAP1 with recombinant p130Cas. IQGAP1
associated specifically with the amino-terminal p130Cas moi-
ety containing the SH3, Proline-rich and kinase substrate
domains. p130Cas tyrosine phosphorylation was required for
its association with IQGAP1 in cells, because overexpression
FIG. 6. IQGAP1 is required for VEGF-induced cell polarization, migration and angiogenesis. A, HUVECS were transfected with two
different siRNAs targeting IQGAP1 at a concentration of 200 nM, or 200 nM of siScr, for 72h and plated onto coverslips to form a confluent
monolayer. The center of the coverslip was scored with a pipette tip, removing cells and leaving a gap. Cells were incubated for 90 min
to allow them to polarize toward the scratch, then fixed in 4% PFA. Cells were stained with antibodies to Actin (red) and GM130 (Golgi
marker; green) and nuclei were visualized using DAPI (blue). Cells were determined to be polarized when the golgi were orientated to face
the scratch. Arrowheads indicate examples of nonpolarized cells. Polarized and nonpolarized cells were counted up to 40 m from the
scratch (indicated by the white dotted line) and expressed as a percentage of cells orientated toward the scratch. One-way ANOVA
indicates a significant reduction in the percentage of cells polarized toward the scratch in the IQGAP1 knockdown samples (***p  0.0005
for both IQGAP1 siRNAs). B, HUVECS were transfected with two different siRNAs targeting IQGAP1 at a concentration of 200 nM, or 200
nM of siScr for 72h and cell migration determined in response to 25 ng/ml VEGF. Values (n  3) are means  s.e.m, expressed as the
number of cells migrating per field; *p  0.05 compared with siScr. Inset panel shows representative blots of siRNA mediated knockdown
of IQGAP1. C, HUVECS were transfected with two different siRNAs targeting IQGAP1 at a concentration of 200 nM, or 200 nM of siScr for
48 h. Cells were trypsinized and 1  104 cells were applied to a confluent monolayer of human dermal fibroblasts in EBM supplemented
with 1% FBS and with or without 25 ng/ml VEGF. Cocultures were incubated for 7 days, with a change of media after 4 days, before being
fixed in ethanol. Endothelial cells were stained with anti-VWF antibody followed by an Alexafluor 488 conjugated secondary antibody. Tube
formation was visualized by scanning in an Incucyte Zoom and parameters of tube formation were determined using the Incucyte Zoom
Angiogenesis software package. Representative images of endothelial tube formation after 7 days coculture with human dermal fibroblasts
either in the absence (upper panels) or presence of VEGF (lower panels) are shown on the left hand panel. Quantification of the network
area as determined by the Incucyte Zoom Angiogenesis software is shown on the right hand panel. Values (n  3) are means  s.e.m, *p 
0.05 versus siScr minus VEGF, #p  0.01 versus siScr plus VEGF.
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of a nontyrosine-phosphorylateable 15F p130Cas mutant pre-
vented the association, whereas IQGAP1 was not necessary
for VEGF-stimulated p130Cas tyrosine phosphorylation. Fur-
thermore, VEGF-induced IQGAP1 association with phospho-
tyrosine was blocked by p130Cas knockdown, and by
inhibition of Src, the main mediator of p130Cas tyrosine
phosphorylation. Our findings do not demonstrate that
IQGAP1 is itself directly phosphorylated by VEGF, as previous
reports have suggested (41), but rather suggest that associ-
ation of IQGAP1 with phoshotyrosine is more likely because of
its association with p130Cas, a protein that is highly tyrosine
phosphorylated in response to VEGF. Whether tyrosine phos-
phorylation of the p130Cas substrate domain is directly in-
volved in IQGAP1 interaction is unclear. The IQGAP1 WW
motif has the potential to associate with Proline-rich domains
(38), raising the possibility that this interaction is with the
p130Cas Proline-rich region. Further work will be necessary
to precisely map the p130Cas-IQGAP1 interaction sites and
the residues involved.
Our findings that IQGAP1 knockdown inhibits VEGF-in-
duced endothelial cell polarization, migration, and angiogen-
esis, support the conclusion that VEGF induced association
between p130Cas and IQGAP1 plays a key role in mediating
VEGF chemotactic signaling. A role for p130Cas association
with IQGAP1 in endothelial cell migration is also supported by
the finding that VEGF markedly increased the concomitant
recruitment of p130Cas and IQGAP1 to focal adhesions on
fibronectin-adherent endothelial cells, whereas VEGF had no
significant effect on FA association of paxillin, a major struc-
tural FA component and target of integrin signaling. These
findings indicate an important role of p130Cas and IQGAP1 in
VEGF-dependent signaling in FAs. A key mechanism that
could mediate the role of the IQGAP1 interaction in endothe-
lial cell migration and angiogenesis is Akt activation and eNOS
ser1177 phosphorylation, a major Akt substrate (42). In support
of this conclusion, we found that p130Cas and IQGAP1
were also both required for VEGF-induced Akt activation,
and for eNOS ser1177 phosphorylation. Our findings suggest
FIG. 7. Role of the p130Cas-IQGAP1 association in VEGF signaling. A, HUVECS were transfected for 48 h with two different siRNAs
targeting IQGAP1 (#1 and #2), p130Cas or siScr, all at a concentration of 200 nM. After incubation in EBM/0.5% FBS for 18 h, cells were
stimulated with or without VEGF for 10 min, lysed and immunoblotted for the proteins indicated. Blots shown are representative of at least 3
independent experiments. B, Quantification of AKT Ser473 and eNOS Ser1177 phosphorylation; values (n  3) are the AKTSer473:AKT and
eNOSSer1177:eNOS ratios expressed as mean  s.e.m. *p  0.05 versus siScr minus VEGF, #p  0.05; ##p  0.01 versus siScr plus VEGF.
C, Association of IQGAP1 and Rac1 increases with VEGF stimulation. After incubation in EBM/0.5% FBS for 18 h, HUVECs were stimulated
with or without VEGF for 10 min. Cells were then lysed and immunoprecipitated with anti-IQGAP1 antibody and immunoblotted for IQGAP1
and Rac1. Quantification of the immunoblots are shown below; values (n  3) are the IQGAP1:Rac1 ratios expressed as mean  s.e.m. *p 
0.05 versus vehicle control minus VEGF, by Student’s t-Test. D, After incubation in EBM/0.5% FBS for 18 h, cells were incubated with 0.1 mM
Rac1 Inhibitor II or 0.1% DMSO (vehicle control) for 4 h, followed by 10 min stimulation with or without VEGF. Cells were lysed and
immunoblotted with antibodies to total and Ser473 phosphorylated Akt. Blots shown are representative of at least 3 independent experiments.
Quantification of the immunoblots are shown below; values (n 3) are the AKTSer473:AKT ratios expressed as mean s.e.m. *p 0.05 versus
vehicle control minus VEGF, #p  0.05 versus vehicle control plus VEGF.
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that IQGAP1 may also modulate Akt activation via an alter-
native pathway mediated via Rac1 that is independent of
p130Cas.
This is the first analysis of the p130Cas interactome. Our
finding that actin-binding and cytoskeletal-associated proteins
represent a major class of p130Cas-interacting proteins is con-
sonant with previous data indicating that p130Cas plays an
important role in integrin-dependent signaling and cell motility.
The identification of IQGAP1 as a major novel p130Cas binding
partner and demonstration of a role for IQGAP1 in VEGF-de-
pendent endothelial cell polarization and migration further rein-
forces the conclusion that the p130Cas interactome is a key
component of the cell machinery important for cell migration,
and plays a central role in the chemotactic response of endo-
thelial cells to VEGF, with important roles in angiogenesis and in
cardiovascular development. Determination of the endothelial
role of p130Cas in explaining the lethal cardiovascular anoma-
lies in p130Cas null mice will require analysis of conditional
endothelial-specific p130Cas-deficient mice. Other findings
from this analysis of the p130Cas interactome indicates previ-
ously unsuspected roles of p130Cas protein-protein interac-
tions in linking the actin cytoskeleton to other cell functions such
as regulation of mRNA stability. These results will be a basis for
directing future studies elucidating the key interacting partners
and mechanisms involved in mediating the functions of
p130Cas and VEGF chemotactic and angiogenic signaling, and
will also have wider implications for understanding mechanisms
underlying cell movement and adhesion.
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